Purpose: Methylprednisolone is widely used during the COVID-19 epidemic. We aimed to evaluate the glucose profile of COVID-19 patients with and without diabetes receiving methylprednisolone.
Methods: 36 patients with COVID-19 admitted to hospital were included: 17 with and 19 without diabetes.
J Clin Endocrinol Metab
April 2023
Context: Previous studies suggest that the complexity of glucose time series may serve as a novel marker of glucose homeostasis.
Objective: We aimed to investigate the relationship between the complexity of glucose time series and all-cause mortality in patients with type 2 diabetes.
Methods: Prospective data of 6000 adult inpatients with type 2 diabetes from a single center were analyzed.
J Clin Endocrinol Metab
October 2021
Context: The interaction of glycated hemoglobin A1c (HbA1c) and glycemic variability in relation to diabetes-related outcomes remains unknown.
Objective: To evaluate the relationship between HbA1c and all-cause mortality across varying degrees of glycemic variability in patients with type 2 diabetes.
Design, Setting, And Patients: This was a prospective study conducted in a single referral center.
Objective: There is growing evidence linking time in range (TIR), an emerging metric for assessing glycemic control, to diabetes-related outcomes. We aimed to investigate the association between TIR and mortality in patients with type 2 diabetes.
Research Design And Methods: A total of 6,225 adult patients with type 2 diabetes were included from January 2005 to December 2015 from a single center in Shanghai, China.